Collybistin mutants with reduced lipid binding affinity disrupt GABAergic synapses by preventing gephyrin synaptic clustering and GABAA receptor targeting and this was in turn reported to trigger epilepsy (Papadopoulos et al., 2015). Here, ARHGEF9 is linked to epilepsy.